The process of drug discovery and development consists of many stages.
DOI:
https://doi.org/10.62752/Keywords:
Target validation, identification, lead optimization, preclinical trials, clinical trials, post-marketing surveillance, and new drug.Abstract
The primary goal of the drug discovery process is to identify a chemical molecule that has therapeutic properties and has the potential to be used in the treatment and potential eradication of illnesses. The approach involves many stages: candidate identification, synthesis, characterization, validation, optimization, screening, and research to evaluate therapeutic efficacy. Once a chemical has shown its efficacy in this research, the process of drug development will begin prior to clinical trials. A treatment that satisfies all regulatory standards and is safe and effective has to undergo through multiple stages of the new drug development process. Our article's main thesis is that the procedure is so long away intricate, and costly that any new medication that is eventually approved for clinical usage must take into account a variety of biological targets, and it may be necessary to develop new research instruments in order to examine each new target. The journey from initial discovery to a marketable drug is a lengthy and arduous procedure. A substantial investment of about US $1 billion is required, and the process from discovery to obtaining an approved drug typically takes between 12 and 15 years. On average, one million compounds are screened, but only one is thoroughly explored at a later stage. The drug undergoes rigorous phase clinical trials before being made accessible to patients. This article provides a comprehensive description of the processes involved in the identification and creation of new pharmaceutical compounds..
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Journal of Pharmaceutical and Healthcare Innovation
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.